Medical Treatment of Ureteral Obstruction Associated With Ovarian Remnants and/or Endometriosis: Report of Three Cases and Review of the Literature

George A Vilos; Jennifer L Marks-Adams; Angelos G Vilos; Ayman Oraif; Basim Abu‐Rafea; Basim Abu-Rafea; Robert F Casper

doi:10.1016/j.jmig.2014.12.153

Medical Treatment of Ureteral Obstruction Associated With Ovarian Remnants and/or Endometriosis: Report of Three Cases and Review of the Literature

George A Vilos, Jennifer L Marks-Adams, Angelos G Vilos, Ayman Oraif, Basim Abu‐Rafea, Basim Abu-Rafea, Robert F Casper

Journal of minimally invasive gynecology · 2014 · vol. 22(3) , pp. 462–468 · doi:10.1016/j.jmig.2014.12.153 · PMID:25533869 · W2012819512

review OA: closed CC0 ⤵ 7 in-corpus citations

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This report details three cases of ureteral obstruction caused by ovarian remnants and/or endometriosis, reviewing existing literature on medical management strategies.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Antineoplastic Agents, Hormonal Danazol Endometriosis Hydronephrosis Hydronephrosis Hydronephrosis Hydronephrosis Postoperative Complications Ureteral Obstruction Ureteral Obstruction Ureteral Obstruction Ureteral Obstruction Antineoplastic Agents, Hormonal Canada Danazol Endometriosis Estrogen Antagonists Estrogen Antagonists Female Gonadotropin-Releasing Hormone

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (88)

Add-back therapy in the treatment of endometriosis-associated pain via openalex
Advances in the management of endometriosis: an update for clinicians via openalex
Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists via openalex
Bilateral ureteral obstruction secondary to endometriosis via openalex
Bilateral Ureteric Obstruction due to Endometriosis Resulting in Unilateral Loss of Renal Function via openalex
Bilateral Ureteric Obstruction Due to Recurrent Endometriosis Associated with Hormone Replacement Therapy via openalex
Bilateral Ureteric Obstruction Secondary to Endometriosis via openalex
Conservative laparoscopic excision of endometriosis by sharp dissection: life table analysis of reoperation and persistent or recurrent disease via openalex
Current Approaches to Optimizing the Treatment of Endometriosis in Adolescents via openalex
Danazol: An antigonadotropic agent in the treatment of pelvic endometriosis via openalex
Danazol inhibition of steroidogenesis in the human corpus luteum. via openalex
Danazol in the Treatment of Ureteral Endometriosis via openalex
Diagnosis and management of endometriosis. via openalex
Endometriosis, Lesions of the Secondary Müllerian System, and Pelvic Mesothelial Proliferations via openalex
Endometriosis with unilateral ureteral obstruction and hypertension. A case report. via openalex
Extragenital endometriosis--a clinicopathological review of a Glasgow hospital experience with case illustrations via openalex
Frequency and Laparoscopic Management of Ovarian Remnant Syndrome via openalex
Gonadotrophin - releasing hormone analogues for endometriosis: bone mineral density via openalex
Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density via openalex
Hormone treatment of endometriosis: The estrogenthreshold hypothesis via openalex
Laparoscopic management of ureteral endometriosis in case of moderate-severe hydroureteronephrosis via openalex
Laparoscopic management of ureteral endometriosis: Our experience via openalex
Laser laparoscopy in the treatment of endometriosis via openalex
Laser laparoscopy in the treatment of endometriosis. A 5‐year study via openalex
Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study via openalex
Leuprolide acetate in the management of ureteral obstruction caused by endometriosis. via openalex
Long-term follow-up of a controlled trial of laser laparoscopy for pelvic pain. via openalex
Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study via openalex
Ovarian Remnant Syndrome via openalex
Ovarian remnant syndrome: diagnostic dilemma and surgical challenge. via openalex
Pathogenesis and pathophysiology of endometriosis via openalex
Pelvic endometriosis and hydroureteronephrosis via openalex
Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome via openalex
Progestin reversal of ureteral endometriosis. via openalex
Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up*1 via openalex
Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis via openalex
Reactive Oxygen Species Controls Endometriosis Progression via openalex
Recurrence of ureteral obstruction caused by endometriosis after danazol therapy via openalex
Retroperitoneal endometriosis causing cyclical ureteral obstruction via openalex
The effects and effectiveness of laparoscopic excision of endometriosis: a prospective study with 2-5 year follow-up via openalex
The Use of Danazol for Ureteral Obstruction Caused by Endometriosis via openalex
TREATMENT WITH DANAZOL OF URETERAL OBSTRUCTION CAUSED BY ENDOMETRIOSIS via openalex
Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain via openalex
[Two cases of ureteral endometriosis]. via openalex
[Ureteral endometriosis] via openalex
Ureteral endometriosis via openalex
Ureteral endometriosis via openalex
Ureteral endometriosis: a case report and a review of the Japanese literature. via openalex
Ureteral Endometriosisin a Female Patient Presentingwith Single-Kidney Anuria via openalex
Vesical Endometriosis: A Review and 2 Case Reports via openalex
When Surgery Is Inappropriate or Inadequate for Endometriosis-Associated Pain: Back to the Future! via openalex
W2046493174 via openalex
W2396785958 via openalex
W2398404805 via openalex
W2019703872 via openalex
W2402395959 via openalex
W2402546523 via openalex
W2018689859 via openalex
W2016891897 via openalex
W2418320338 via openalex
W2008017869 via openalex
W1618997004 via openalex
W190740743 via openalex
W2443739481 via openalex
W170259557 via openalex
W3144701148 via openalex
W4233491085 via openalex
W4285719527 via openalex
W4290264460 via openalex
W6600331236 via openalex
W6607764366 via openalex
W6608139517 via openalex
W6624558364 via openalex
W6657029878 via openalex
W2100281208 via openalex
W6717783372 via openalex
W6840775345 via openalex
W6840958863 via openalex
W6716955854 via openalex
W2124083858 via openalex
W2131501232 via openalex
W2078042686 via openalex
W2049619918 via openalex
W2146493861 via openalex
W2154095911 via openalex
W2046683546 via openalex
W2159203244 via openalex
W2160637231 via openalex

Cited by (7)

Source provenance

europepmc: last seen: 2026-06-12T06:13:51.797165+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-05-13T22:18:04.362919+00:00

License: CC0 · commercial use OK

[1] Add-back therapy in the treatment of endometriosis-associated pain via openalex

[2] Advances in the management of endometriosis: an update for clinicians via openalex

[3] Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists via openalex

[4] Bilateral ureteral obstruction secondary to endometriosis via openalex

[5] Bilateral Ureteric Obstruction due to Endometriosis Resulting in Unilateral Loss of Renal Function via openalex

[6] Bilateral Ureteric Obstruction Due to Recurrent Endometriosis Associated with Hormone Replacement Therapy via openalex

[7] Bilateral Ureteric Obstruction Secondary to Endometriosis via openalex

[8] Conservative laparoscopic excision of endometriosis by sharp dissection: life table analysis of reoperation and persistent or recurrent disease via openalex

[9] Current Approaches to Optimizing the Treatment of Endometriosis in Adolescents via openalex

[10] Danazol: An antigonadotropic agent in the treatment of pelvic endometriosis via openalex

[11] Danazol inhibition of steroidogenesis in the human corpus luteum. via openalex

[12] Danazol in the Treatment of Ureteral Endometriosis via openalex

[13] Diagnosis and management of endometriosis. via openalex

[14] Endometriosis, Lesions of the Secondary Müllerian System, and Pelvic Mesothelial Proliferations via openalex

[15] Endometriosis with unilateral ureteral obstruction and hypertension. A case report. via openalex

[16] Extragenital endometriosis--a clinicopathological review of a Glasgow hospital experience with case illustrations via openalex

[17] Frequency and Laparoscopic Management of Ovarian Remnant Syndrome via openalex

[18] Gonadotrophin - releasing hormone analogues for endometriosis: bone mineral density via openalex

[19] Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density via openalex

[20] Hormone treatment of endometriosis: The estrogenthreshold hypothesis via openalex

[21] Laparoscopic management of ureteral endometriosis in case of moderate-severe hydroureteronephrosis via openalex

[22] Laparoscopic management of ureteral endometriosis: Our experience via openalex

[23] Laser laparoscopy in the treatment of endometriosis via openalex

[24] Laser laparoscopy in the treatment of endometriosis. A 5‐year study via openalex

[25] Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study via openalex

[26] Leuprolide acetate in the management of ureteral obstruction caused by endometriosis. via openalex

[27] Long-term follow-up of a controlled trial of laser laparoscopy for pelvic pain. via openalex

[28] Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study via openalex

[29] Ovarian Remnant Syndrome via openalex

[30] Ovarian remnant syndrome: diagnostic dilemma and surgical challenge. via openalex

[31] Pathogenesis and pathophysiology of endometriosis via openalex

[32] Pelvic endometriosis and hydroureteronephrosis via openalex

[33] Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome via openalex

[34] Progestin reversal of ureteral endometriosis. via openalex

[35] Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up*1 via openalex

[36] Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis via openalex

[37] Reactive Oxygen Species Controls Endometriosis Progression via openalex

[38] Recurrence of ureteral obstruction caused by endometriosis after danazol therapy via openalex

[39] Retroperitoneal endometriosis causing cyclical ureteral obstruction via openalex

[40] The effects and effectiveness of laparoscopic excision of endometriosis: a prospective study with 2-5 year follow-up via openalex

[41] The Use of Danazol for Ureteral Obstruction Caused by Endometriosis via openalex

[42] TREATMENT WITH DANAZOL OF URETERAL OBSTRUCTION CAUSED BY ENDOMETRIOSIS via openalex

[43] Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain via openalex

[44] [Two cases of ureteral endometriosis]. via openalex

[45] [Ureteral endometriosis] via openalex

[46] Ureteral endometriosis via openalex

[47] Ureteral endometriosis via openalex

[48] Ureteral endometriosis: a case report and a review of the Japanese literature. via openalex

[49] Ureteral Endometriosisin a Female Patient Presentingwith Single-Kidney Anuria via openalex

[50] Vesical Endometriosis: A Review and 2 Case Reports via openalex

[51] When Surgery Is Inappropriate or Inadequate for Endometriosis-Associated Pain: Back to the Future! via openalex

[52] W2046493174 via openalex

[53] W2396785958 via openalex

[54] W2398404805 via openalex

[55] W2019703872 via openalex

[56] W2402395959 via openalex

[57] W2402546523 via openalex

[58] W2018689859 via openalex

[59] W2016891897 via openalex

[60] W2418320338 via openalex

[61] W2008017869 via openalex

[62] W1618997004 via openalex

[63] W190740743 via openalex

[64] W2443739481 via openalex

[65] W170259557 via openalex

[66] W3144701148 via openalex

[67] W4233491085 via openalex

[68] W4285719527 via openalex

[69] W4290264460 via openalex

[70] W6600331236 via openalex

[71] W6607764366 via openalex

[72] W6608139517 via openalex

[73] W6624558364 via openalex

[74] W6657029878 via openalex

[75] W2100281208 via openalex

[76] W6717783372 via openalex

[77] W6840775345 via openalex

[78] W6840958863 via openalex

[79] W6716955854 via openalex

[80] W2124083858 via openalex

[81] W2131501232 via openalex

[82] W2078042686 via openalex

[83] W2049619918 via openalex

[84] W2146493861 via openalex

[85] W2154095911 via openalex

[86] W2046683546 via openalex

[87] W2159203244 via openalex

[88] W2160637231 via openalex